Ga Hye Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ga Hye Lee has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Won-Woo Lee
Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea
4 shared publications Bonah Kim
BK21Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea
1 shared publicationChan Joo Lee
Department of Health Promotion and Disease Prevention, Severance Hospital, Seoul, South Korea
1 shared publication- Eun Bong Lee
Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
1 shared publication - Eun Young Lee
Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
1 shared publication Hee Tae Yu
Division of Cardiology, Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Wiley in Clinical & Translational Immunology
- Vol. 9 (4) , e1124
Immunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors
Objectives: Paediatric and adolescent patients in need of allogeneic haematopoietic stem cell transplantation (HSCT) generally receive stem cells from older, unrelated or parental donors when a sibling donor is not available. Despite encouraging clinical outcomes, it has been suggested that immune reconstitution accompanied by increased replicative stress and a large difference between donor and recipient age may worsen immunosenescence in paediatric recipients.Methods: In this study, paired samples were collected at the same time from donors and recipients of haploidentical haematopoietic stem cell transplantation (HaploSCT). We then conducted flow cytometry‐based phenotypic and functional analyses and telomere length (TL) measurements of 21 paired T‐cell sets from parental donors and children who received T‐cell‐replete HaploSCT with post‐transplant cyclophosphamide (PTCy).Results: Senescent T cells, CD28− or CD57+ cells, were significantly expanded in patients. Further, not only CD4+CD28− T cells, but also CD4+CD28+ T cells showed reduced cytokine production capacity and impaired polyfunctionality compared with parental donors, whereas their TCR‐mediated proliferation capacity was comparable. Of note, the TL in patient T cells was preserved, or even slightly longer, in senescent T cells compared with donor cells. Regression analysis showed that senescent features of CD4+ and CD8+ T cells in patients were influenced by donor age and the frequency of CD28− cells, respectively.Conclusion: Our data suggest that in paediatric HaploSCT, premature immunosenescent changes occur in T cells from parental donors, and therefore, long‐term immune monitoring should be conducted.
- 1 January 2020
- Published by Wiley in Clinical & Translational Immunology
- Vol. 9 (4) , e1124
Open AccessImmunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors
Objectives: Paediatric and adolescent patients in need of allogeneic haematopoietic stem cell transplantation (HSCT) generally receive stem cells from older, unrelated or parental donors when a sibling donor is not available. Despite encouraging clinical outcomes, it has been suggested that immune reconstitution accompanied by increased replicative stress and a large difference between donor and recipient age may worsen immunosenescence in paediatric recipients.Methods: In this study, paired samples were collected at the same time from donors and recipients of haploidentical haematopoietic stem cell transplantation (HaploSCT). We then conducted flow cytometry‐based phenotypic and functional analyses and telomere length (TL) measurements of 21 paired T‐cell sets from parental donors and children who received T‐cell‐replete HaploSCT with post‐transplant cyclophosphamide (PTCy).Results: Senescent T cells, CD28− or CD57+ cells, were significantly expanded in patients. Further, not only CD4+CD28− T cells, but also CD4+CD28+ T cells showed reduced cytokine production capacity and impaired polyfunctionality compared with parental donors, whereas their TCR‐mediated proliferation capacity was comparable. Of note, the TL in patient T cells was preserved, or even slightly longer, in senescent T cells compared with donor cells. Regression analysis showed that senescent features of CD4+ and CD8+ T cells in patients were influenced by donor age and the frequency of CD28− cells, respectively.Conclusion: Our data suggest that in paediatric HaploSCT, premature immunosenescent changes occur in T cells from parental donors, and therefore, long‐term immune monitoring should be conducted.
- Open Access
- 8 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-16
Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)
Progressive renal failure causes uremia-related immune dysfunction, which features a chronic inflammatory milieu. Given the central role of end-stage renal disease (ESRD)-related immune dysfunction in the pathogenesis of cardiovascular diseases (CVDs), much attention has been focused on how uremic toxins affect cellular immunity and the mechanisms underlying pathogenesis of atherosclerosis in ESRD patients. Here, we investigated the characteristics of monocytes and CD4+ T cells in ESRD patients and the immune responses induced by indoxyl sulfate (IS), a key uremic toxin, in order to explore the pathogenic effects of these cells on vascular endothelial cells. In ESRD patients, monocytes respond to IS through the aryl hydrocarbon receptor (AhR) and consequently produce increased levels of TNF-α. Upon stimulation with TNF-α, human vascular endothelial cells produce copious amounts of CX3CL1, a chemokine ligand of CX3CR1 that is highly expressed on CD4+CD28−T cells, the predominantly expanded cell type in ESRD patients. A migration assay showed that CD4+CD28− T cells were preferentially recruited by CX3CL1. Moreover, activated CD4+CD28− T cells exhibited cytotoxic capability allowing for the induction of apoptosis in HUVECs. Our findings suggest that in ESRD, IS-mediated immune dysfunction may cause vascular endothelial cell damage and thus, this toxin plays a pivotal role in the pathogenesis of CVD.
- 8 June 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-16
Open AccessIndoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)
Progressive renal failure causes uremia-related immune dysfunction, which features a chronic inflammatory milieu. Given the central role of end-stage renal disease (ESRD)-related immune dysfunction in the pathogenesis of cardiovascular diseases (CVDs), much attention has been focused on how uremic toxins affect cellular immunity and the mechanisms underlying pathogenesis of atherosclerosis in ESRD patients. Here, we investigated the characteristics of monocytes and CD4+ T cells in ESRD patients and the immune responses induced by indoxyl sulfate (IS), a key uremic toxin, in order to explore the pathogenic effects of these cells on vascular endothelial cells. In ESRD patients, monocytes respond to IS through the aryl hydrocarbon receptor (AhR) and consequently produce increased levels of TNF-α. Upon stimulation with TNF-α, human vascular endothelial cells produce copious amounts of CX3CL1, a chemokine ligand of CX3CR1 that is highly expressed on CD4+CD28−T cells, the predominantly expanded cell type in ESRD patients. A migration assay showed that CD4+CD28− T cells were preferentially recruited by CX3CL1. Moreover, activated CD4+CD28− T cells exhibited cytotoxic capability allowing for the induction of apoptosis in HUVECs. Our findings suggest that in ESRD, IS-mediated immune dysfunction may cause vascular endothelial cell damage and thus, this toxin plays a pivotal role in the pathogenesis of CVD.
- Open Access
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (12) , 1967-1973
Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks
Lee JH, et al. J Korean Med Sci. 2017 Dec;32(12):1967-1973. https://doi.org/10.3346/jkms.2017.32.12.1967
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (12) , 1967-1973
Open AccessElderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks
Lee JH, et al. J Korean Med Sci. 2017 Dec;32(12):1967-1973. https://doi.org/10.3346/jkms.2017.32.12.1967
- Open Access
- 1 January 2016
- Published by XMLink in Immune Network
- Vol. 16 (6) , 322-329
Unusual CD4+CD28−T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
Lee GH, et al. Immune Netw. 2016 Dec;16(6):322-329. https://doi.org/10.4110/in.2016.16.6.322
- 1 January 2016
- Published by XMLink in Immune Network
- Vol. 16 (6) , 322-329
Open AccessUnusual CD4+CD28−T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
Lee GH, et al. Immune Netw. 2016 Dec;16(6):322-329. https://doi.org/10.4110/in.2016.16.6.322